Literature DB >> 21413933

Hepatic stellate cells stimulate HCC cell migration via laminin-5 production.

Angela Santamato1, Emilia Fransvea, Francesco Dituri, Alessandra Caligiuri, Michele Quaranta, Tomoaki Niimi, Massimo Pinzani, Salvatore Antonaci, Gianluigi Giannelli.   

Abstract

Activated HSCs (hepatic stellate cells) are the main source of extracellular matrix proteins present in cirrhotic liver on which HCC (hepatocellular carcinoma) commonly develops. HCC cells behave differently according to differences in the surrounding microenvironment. In the present study, we have investigated a mechanism whereby HSCs modulate the migratory activity of HCC cells. We used primary cultures of human HSCs to investigate their effect on Hep3B, Alexander, HLE and HLF HCC cells. The expression of Ln-5 (laminin-5) was documented at transcript and protein levels both in vitro and in vivo. HCC cells strongly adhere, migrate and spread in the presence of HSC-conditioned medium and of co-culture. HSCs produce and secrete Ln-5 in the CM (conditioned medium). The electrophoretic pattern of secreted Ln-5 is consistent with that of a migratory substrate, showing the presence of the γ2x fragment. Blocking antibodies against Ln-5 inhibit HCC migration in the presence of HSC-CM. HCC cells migrate very poorly in the presence of Ln-5 immunodepleted HSC-CM. HCC migration in the presence of HSCs is dependent on the MEK [MAPK (mitogen-activated protein kinase)/ERK (extracellular-signal-regulated kinase) kinase]/ERK pathway, but not the PI3K (phosphoinositide 3-kinase)/Akt pathway. HSC-CM, as well as Ln-5, activates the MEK/ERK but not the PI3K/Akt pathway. In human HCC tissues, Ln-5 is mainly distributed along α-SMA (smooth muscle actin)-positive cells, whereas in peritumoural tissues, Ln-5 is absent. HSCs stimulate HCC migration via the production and secretion of Ln-5.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21413933     DOI: 10.1042/CS20110002

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  22 in total

Review 1.  Targeting the tumor stroma in hepatocellular carcinoma.

Authors:  Femke Heindryckx; Pär Gerwins
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma.

Authors:  Bhavna Rani; Yuan Cao; Andrea Malfettone; Ciprian Tomuleasa; Isabel Fabregat; Gianluigi Giannelli
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 3.  The double edge sword of fibrosis in cancer.

Authors:  Chelsea Chandler; Tianshi Liu; Ronald Buckanovich; Lan G Coffman
Journal:  Transl Res       Date:  2019-02-21       Impact factor: 7.012

4.  Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Semin Liver Dis       Date:  2020-04-02       Impact factor: 6.115

Review 5.  The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.

Authors:  Silvia Affo; Le-Xing Yu; Robert F Schwabe
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

Review 6.  Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies.

Authors:  Don C Rockey
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-07       Impact factor: 11.382

Review 7.  Hepatic stellate cells: central modulators of hepatic carcinogenesis.

Authors:  Alexandra I Thompson; Kylie P Conroy; Neil C Henderson
Journal:  BMC Gastroenterol       Date:  2015-05-27       Impact factor: 3.067

8.  Causal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular Carcinoma.

Authors:  Julia C Engelmann; Thomas Amann; Birgitta Ott-Rötzer; Margit Nützel; Yvonne Reinders; Jörg Reinders; Wolfgang E Thasler; Theresa Kristl; Andreas Teufel; Christian G Huber; Peter J Oefner; Rainer Spang; Claus Hellerbrand
Journal:  PLoS Comput Biol       Date:  2015-05-28       Impact factor: 4.475

9.  Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.

Authors:  Fatima Rangwala; Kevin P Williams; Ginger R Smith; Zainab Thomas; Jennifer L Allensworth; H Kim Lyerly; Anna Mae Diehl; Michael A Morse; Gayathri R Devi
Journal:  BMC Cancer       Date:  2012-09-10       Impact factor: 4.430

10.  HDAC inhibitors in experimental liver and kidney fibrosis.

Authors:  Katrien Van Beneden; Inge Mannaerts; Marina Pauwels; Christiane Van den Branden; Leo A van Grunsven
Journal:  Fibrogenesis Tissue Repair       Date:  2013-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.